{"name":"iCell Gene Therapeutics","slug":"icell-gene-therapeutics","ticker":"","exchange":"","domain":"icellgene.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPOGNWRHpGbVZmZEJBb29aTWlDaWlPX0xqLWRqSDlTT2tUTk9BWEc1WEVpQlVuS2FOWGxwQXE3elpTREFDZ1JhMXM3UTBUQndGOWZGNV9HZk0tUjVON19QbnJCcS16RlFDZ2hsVHdvb2JWYWw2bHEyNVRZR3VYa3lSSmh0Q3NuSFJ4TkdhWFVLd3o2ck9uMWRMa2pkUnN4eUU4SWc?oc=5","date":"2026-02-09","type":"pipeline","source":"Pharmaceutical Commerce","summary":"Designing Patient Hubs Purpose-Built for Cell and Gene Therapies - Pharmaceutical Commerce","headline":"Designing Patient Hubs Purpose-Built for Cell and Gene Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNLThIa3RDcUtHdU5LcU9FSUxKU3Zaa0Y2MkFHUlZyMkFIU0RUUWpHZFdzblpSNVoyQjVRVUVwYklxdDNQZDdwTVRBVjJkTFVhNVhiM3NIUGJLMlpVUmtmZ1p1ZVp2RFlJNktOZnY3U09xY0hBRy1lZDhwTGFVQkxWdUFGYUNWT2s?oc=5","date":"2026-01-12","type":"regulatory","source":"pharmaphorum","summary":"FDA removes barriers to cell, gene therapy development - pharmaphorum","headline":"FDA removes barriers to cell, gene therapy development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPZ1ZqbTZVWGJ4a3FHMHFUSy1lbmlDalpiSk0wcXBjRmU0MGRPRG9JcW5xN0lkT2tIcXpOQzUzS3Q3X1NGUng3SldEbWhHSGl0WWowQldldDYzdVc1OVJXbC1aTTFPZWRfQWFMMmNYTUp6SHVONDhnN1NmaWNCOW52N21HM3BKUmtKdXRMRGtDRDdSX3Z6Q19kWlJvWWZzZ1BkNGw1dzZXZFRrcjhEdE43RkdyLTVFUQ?oc=5","date":"2026-01-12","type":"regulatory","source":"Pharmaceutical Technology","summary":"FDA increases manufacturing flexibility for cell and gene therapies - Pharmaceutical Technology","headline":"FDA increases manufacturing flexibility for cell and gene therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQOEkxb2liOWJEZG40THRuclJBVm1RbWxDRzRSZFBiVndSOEF2aG5kLTdlQUp4ZVBadHBQMFVDeFc2ZUw5NkNETW5KZnBmVmJ5aVBGelI5eDNyeDVhMmp4ZXlLU0thQVNNU3VZdHVoX1lWX01vTzJwSWxXS25EY0xZZ0NPWFN3Z3VDeGYwMkNfNGhWR3I3djJjTnFfUFU3a2d2VlhSaU9UMFcwY2xvRTlvM1NZNUROR1U?oc=5","date":"2025-12-10","type":"pipeline","source":"Pharmaceutical Technology","summary":"Cell and gene therapy investment strategy pivots as funding dries up - Pharmaceutical Technology","headline":"Cell and gene therapy investment strategy pivots as funding dries up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNcFNsbWdrMlRDcmlOUVhXalFPZkplZjN0T1gyMkZQTWM4dDdybXZ3YlZWZzFQekJtbHNuZkpxU1lYSnY1NERwOFE5M3c1aExFdG1CXy1oRVg3OTFnREVfbXM2VklEa1NjVm84MDl5Qi14dFV0S05IdGdERm1lUlJzOGF2a05wSV9UR1pteWFrSGZ5UGU2U2NoT0xpRlVCREktblg2elR3MEdyRDhWT1Z4OW84T3NNWHUtWC1pa0VxNll0WEt0dFF4R0FqMjFYU2xBTkpWSjUzQUlGZXJsSVE?oc=5","date":"2025-12-09","type":"pipeline","source":"PharmaLive","summary":"Cell and gene therapy investments shift as budgets tighten and big pharma recalibrates towards strategic acquisitions - PharmaLive","headline":"Cell and gene therapy investments shift as budgets tighten and big pharma recalibrates towards strategic acquisitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNY0xZWUItZzcwb3J5OEFyd3l1WWhKSE84dFZJN0drYTN4QXN3Zno5d1B1TDlUMmdmOWQzTDIyclM0Y1F5MnJYbG1ZdTRZZlFhb3Jmem14RzcwZlkwOXVnQWZsaURwTXliQWNDbVp3aFdtY3FwT01xQlhaSUZwXzByQkNXUDd5alg1c09zU2prbzREQWJ1cFpqS1JLdzNYX0RvZkd3SE42T0hIZ2lXektpSk5vaTk0NXZmWHdtWEhzSTk0OFZUeFE?oc=5","date":"2025-10-09","type":"pipeline","source":"Citeline News & Insights","summary":"Big Pharma Still Sees Value In Cell And Gene Therapy’s Next Wave - Citeline News & Insights","headline":"Big Pharma Still Sees Value In Cell And Gene Therapy’s Next Wave - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOblc3emZYdDRMMDdGTWFEUjdONUFxX2tPeThHWmVlYTNmSTY0UXRqbUFMYUgxUzBycTd1OHNnR2MwenEtMktxWGZwM0tnVWdBTW1lblZ4ZFNaUl9ydjVFVU1Qb2hQV0M2NjFJakxlNmo1aFJaQ1VqdU5qd3U1SDkxZ3QxRzZ2ejNFZFlKVmlFdG53X045RFE?oc=5","date":"2025-10-06","type":"pipeline","source":"Contract Pharma","summary":"Lonza Expands Cell and Gene Therapy Portfolio - Contract Pharma","headline":"Lonza Expands Cell and Gene Therapy Portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPNG05b05XWE13cHUzQk5IN3R5blNFQmpjSDZKZXlrc2lFZDhMM1BDRU5Xcm5Kb1preDM4cDRqYjdveTEyY2RRUGVRVGZOaEx3RFAxMnlXNG1uNkRielExSWt6RGloVjE5dkdrdE5HUXN3aXJDQVk1SzRzbkFZZXctU2Z2U0lhUUxGeUhSZVVWVWNRd0FhaFllOEdFb1J0QQ?oc=5","date":"2025-10-02","type":"pipeline","source":"DCAT Value Chain Insights","summary":"Bio/Pharma Industry Radar: The In’s and Out’s of Cell & Gene Therapies - DCAT Value Chain Insights","headline":"Bio/Pharma Industry Radar: The In’s and Out’s of Cell & Gene Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPVEN5djZyZjA5NDA2VVBHc3lYTURyVjZvUFg5dEdOdjVHcnhQRU1CYVJIS1pSOXJ6dS1yc0EyMzJlZHROa3ZrcDFoTjJSaFZ1QlV6ZzF2SVlFU0QxX0ZkMGhzMnlfc2oxSVhlR0Jkb1RHTXBrU0ZjbmlaTC1BOHpuVmJqcFpmWE53QjN4bGtDZXdic1lDaGUwQmpDdENpVnV2dWtINkFEV2o3VngzVDNhWkZkWF8zLTRZTmlYUVdlVzJ0b19DY3hEckJ3?oc=5","date":"2025-09-25","type":"pipeline","source":"Reuters","summary":"Focus: Parkinson's disease at forefront of Bayer bet on cell and gene therapies - Reuters","headline":"Focus: Parkinson's disease at forefront of Bayer bet on cell and gene therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOTDF1NVhUaUNBT0dmOGJJRmN5SjFFZXU5dXFPWG9RMUloVVMzcjhWelZoM2VZaGNGOHE5RXFGUDZXVXBsZ283T1dyODM4a1RERFk4dU1tTnZPNWZhRXJoZkNBWktsTGRfaEQyNzdzYmEtLS12MEo2OTYzUVp0OXhLZFgwX0dQaUVLYlhpNnJrdzBxWURCRHh4b0tFWGZZYktoaVZReEY4cm45YUltNHBUbUJYdV9NUmg0RkVFMmNjY2pEUmRuU3BkOFk1V1dpSDFabDlrZGZMWE5VVjVVVVVFX3JRaGY?oc=5","date":"2025-09-24","type":"pipeline","source":"BioSpectrum Asia","summary":"eXmoor Pharma and Siam Bioscience to establish leading cell & gene therapy services in Southeast Asia - BioSpectrum Asia","headline":"eXmoor Pharma and Siam Bioscience to establish leading cell & gene therapy services in Southeast Asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQR0JORDJfTUpab0RLeHFoZko1YkxYWlFEYWpaU1RhbFJuR2lIZENfbVpKcFZ3VTVUMDJ4VDFMb19qcnZyajBWZ0lkeDZEQXF6UlFqVGhFbjZVd3dBNFYzamxJbTZlUzJtaGdGMzdHd190TVFkRlNDcDJiZHpKa2NzcTc5YTdDeFJsMHI1VGR4eFZlUUlvYm4yMmhDdnFYMjhxd29kbWhmMjVGU3VzLTl2UWk3ZUV1QzVsZ2c?oc=5","date":"2025-09-19","type":"pipeline","source":"European Pharmaceutical Review","summary":"Bayer breaks ground on German cell and gene therapy centre - European Pharmaceutical Review","headline":"Bayer breaks ground on German cell and gene therapy centre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOLXFwN2YxMThOZEQ4Zm5EWnM5X3hZWlozQkJ6a3BFM0tiTGd6TXgwSDRNajE3SVBoNVU3MlJ4eDR4OXhJa2F6bGt2NmZwd2Jjc3A1UExZRm5SeHZvSGVOMlk3SjZ6aWpsb2pYQ1FvNzRnVXpxb3RPcVZpaUg4Q1RUd2RKSkZJdU9l?oc=5","date":"2025-06-03","type":"pipeline","source":"Contract Pharma","summary":"Early Choices, Lasting Impact in Cell & Gene Therapy - Contract Pharma","headline":"Early Choices, Lasting Impact in Cell & Gene Therapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}